Delivery Order SPE2DR25D1201-SPE2DR26FAKKL
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,732.24 on January 7, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, awarded by the Defense Logistics Agency (DLA), the Department of Defense's supply chain management organization responsible for medical procurement. Performance will be completed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 26, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a firm fixed price ceiling value of $19,092.10. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 29, 2025, and represents a routine pharmaceutical procurement supporting federal medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $11,878.85. This competitive, firm fixed-price delivery order is set to be completed by November 7, 2025, and represents a single-line procurement under AmerisourceBergen's larger pharmaceutical supply framework with the federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $30,051.78 by the Defense Logistics Agency on October 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,464.31 on January 6, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). This non-set-aside, competitively awarded contract with firm fixed pricing is funded by the Defense Logistics Agency (DLA) and is scheduled for completion by January 7, 2026. The award represents a task order issued under AmerisourceBergen's parent company,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 22, 2025, by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets (90-count packages). This non-set-aside, competitively awarded delivery order carries a firm fixed price ceiling value of $23,196.13 and is scheduled for ultimate completion on December 23, 2025. The award represents a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,684.94 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $17,412.62 for 90 tablets of Jardiance 25 mg by the Defense Logistics Agency (DLA). This competitively awarded, firm fixed-price delivery order is set to be completed by October 17, 2025, and represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on November 18, 2025, for 90-count tablets of Jardiance 10 mg. This firm fixed-price delivery order has a ceiling value of $6,807.46 and is scheduled for completion by November 19, 2025. The contract does not include a set-aside designation, indicating it was awarded through open competition. This...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKKLDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,053.12 on January 8, 2026, for 90-count tablets of Jardiance 25 mg. This is a firm fixed-price, non-set-aside contract funded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense responsible for supplying medical and pharmaceutical products to military healthcare systems. The delivery order is expected to be completed by January 9, 2026, reflecting the rapid fulfillment typical of pharmaceutical supply chain operations supporting federal medical procurement. This delivery order is executed under AmerisourceBergen's parent company, Cencora, Inc.'s, Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.999 billion through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications, vaccines, and medical supplies to military treatment facilities and veteran healthcare programs worldwide. AmerisourceBergen's demonstrated capability to compete successfully on an open and full basis, combined with its extensive portfolio of therapeutic medications including diabetes treatments like Jardiance, positions the company as a critical vendor for federal military and defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 1/7/26 |